Related references
Note: Only part of the references are listed.Discovery of a Series of Pyrazinone RORγ Antagonists and Identification of the Clinical Candidate BI 730357
Christian Harcken et al.
ACS MEDICINAL CHEMISTRY LETTERS (2021)
Tricyclic-Carbocyclic RORγt Inverse Agonists-Discovery of BMS-986313
Michael G. Yang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Discovery of a novel RORγ antagonist with skin-restricted exposure for topical treatment of mild to moderate psoriasis
Suxing Liu et al.
SCIENTIFIC REPORTS (2021)
Retinoic acid-related orphan receptor gamma t (RORγt) inverse agonists/antagonists for the treatment of inflammatory diseases - where are we presently?
Christian Gege
EXPERT OPINION ON DRUG DISCOVERY (2021)
Thymic Lymphomas in a 6-Month rasH2-Tg Mouse Carcinogenicity Study With the RORγt Inverse Agonist, BMS-986251
Helen G. Haggerty et al.
TOXICOLOGICAL SCIENCES (2021)
Preclinical and clinical characterization of the RORγt inhibitor JNJ-61803534
Xiaohua Xue et al.
SCIENTIFIC REPORTS (2021)
(Inverse) Agonists of Retinoic Acid-Related Orphan Receptor γ: Regulation of Immune Responses, Inflammation, and Autoimmune Disease
Anton M. Jetten et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 60 (2020)
A novel series of cysteine-dependent, allosteric inverse agonists of the nuclear receptor RORγt
Xin Jiang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
Pharmacokinetics, pharmacodynamics and safety of the inverse retinoic acid-related orphan receptor γ agonist AZD0284
Sara Asimus et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2020)
Discovery of N-(Indazol-3-yl)piperidine-4-carboxylic Acids as RORγt Allosteric Inhibitors for Autoimmune Diseases
Hongjun Zhang et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Discovery of [1,2,4]Triazolo[1,5-a]pyridine Derivatives as Potent and Orally Bioavailable RORγt Inverse Agonists
Ryota Nakajima et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Discovery of BMS-986251: A Clinically Viable, Potent, and Selective RORγt Inverse Agonist
Robert J. Cherney et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Optimization and biological evaluation of thiazole-bis-amide inverse agonists of RORγt
Christian Gege et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
Discovery of Potent and Orally Bioavailable Inverse Agonists of the Retinoic Acid Receptor-Related Orphan Receptor C2
Stefan von Berg et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
5,6,7,8-Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine derivatives as inhibitors of full-length RORγt
Chuyu Lao et al.
BIOORGANIC CHEMISTRY (2019)
Retinoic acid receptor-related orphan receptor gamma-t (RORγt) inhibitors in clinical development for the treatment of autoimmune diseases: a patent review (2016-present)
Nannan Sun et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2019)
Inhibition of Interleukin-23-Mediated Inflammation with a Novel Small Molecule Inverse Agonist of RORγt
Stephen B. Gauld et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Mini Review: New Treatments in Psoriatic Arthritis. Focus on the IL-23/17 Axis
Lazaros I. Sakkas et al.
FRONTIERS IN PHARMACOLOGY (2019)
Structure-Based and Property-Driven Optimization of N-Aryl Imidazoles toward Potent and Selective Oral RORγt Inhibitors
Klemens Hoegenauer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
RORγt inhibition selectively targets IL-17 producing iNKT and γδ-T cells enriched in Spondyloarthritis patients
Koen Venken et al.
NATURE COMMUNICATIONS (2019)
Practical application of ligand efficiency metrics in lead optimisation
James S. Scott et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
A phase I randomized controlled trial to evaluate safety and clinical effect of topically applied GSK2981278 ointment in a psoriasis plaque test
E. G. Kang et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
Discovery and Characterization of CD12681, a Potent ROR Inverse Agonist, Preclinical Candidate for the Topical Treatment of Psoriasis
Gilles Ouvry et al.
CHEMMEDCHEM (2018)
Role of the IL-23/IL-17 Axis in Psoriasis and Psoriatic Arthritis: The Clinical Importance of Its Divergence in Skin and Joints
Marie-Astrid Boutet et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Combating Autoimmune Diseases With Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc) Inhibitors: Hits and Misses
Vrajesh B. Pandya et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Potent and Orally Bioavailable Inverse Agonists of RORγt Resulting from Structure-Based Design
Frank Narjes et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Discovery of 3-Cyano-N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridin-5-yObenzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor Related Orphan Receptor C2 Inverse Agonist
Mark E. Schnute et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Secukinumab provides better relief from the impact of psoriasis on daily activities and personal relationships than etanercept: results of two phase 3 placebo-controlled randomized clinical trials in moderate-to-severe psoriasis
Neil J. Korman et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2017)
Retinoid-related orphan receptor γ (RORγ) adult induced knockout mice develop lymphoblastic lymphoma
Maria Liljevald et al.
AUTOIMMUNITY REVIEWS (2016)
Recent progress on nuclear receptor RORγ modulators
Patrick Cyr et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
A Progenitor Cell Expressing Transcription Factor RORγt Generates All Human Innate Lymphoid Cell Subsets
Steven D. Scoville et al.
IMMUNITY (2016)
Small molecule mediated inhibition of RORγ-dependent gene expression and autoimmune disease pathology in vivo
Daliya Banerjee et al.
IMMUNOLOGY (2016)
IL-17 in Chronic Inflammation: From Discovery to Targeting
Audrey Beringer et al.
TRENDS IN MOLECULAR MEDICINE (2016)
Inhibition of interleukin-17, interleukin-23 and the TH17 cell pathway in the treatment of psoriatic arthritis and psoriasis
Philip J. Mease
CURRENT OPINION IN RHEUMATOLOGY (2015)
Interleukin-17 and innate immunity in infections and chronic inflammation
Natasa Isailovic et al.
JOURNAL OF AUTOIMMUNITY (2015)
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis
Dominique Baeten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Identification of an allosteric binding site for RORγt inhibition
Marcel Scheepstra et al.
NATURE COMMUNICATIONS (2015)
Modulators of the Nuclear Receptor Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc)
Benjamin P. Fauber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing
Sarah L. Gaffen et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Application of In Silico, In Vitro and Preclinical Pharmacokinetic Data for the Effective and Efficient Prediction of Human Pharmacokinetics
Kenneth H. Grime et al.
MOLECULAR PHARMACEUTICS (2013)
Synthetic modulators of the retinoic acid receptor-related orphan receptors
Theodore M. Kamenecka et al.
MEDCHEMCOMM (2013)
Targeting IL-17and TH17 cells in chronic inflammation
Pierre Miossec et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Dynamic Kinetic Resolution of 1,3-Dihydro-2H-isoindole-1-carboxylic Acid Methyl Ester: Asymmetric Transformations toward Isoindoline Carbamates
Rolberto Moran-Ramallal et al.
ORGANIC LETTERS (2012)
Drug-induced hERG Block and Long QT Syndrome
Harry J. Witchel
CARDIOVASCULAR THERAPEUTICS (2011)
Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance Part I
Shu-Feng Zhou
CLINICAL PHARMACOKINETICS (2009)
The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells
Ivaylo I. Ivanov et al.
CELL (2006)
Share Paper
